Share on Facebook
Share on Twitter
Share on LinkedIn

The U.S. Food and Drug Administration said on Thursday that certain insulin pumps of Medtronic Plc were being recalled due to a potential risk of them being hacked.

The drug regulator said it was not aware of any confirmed reports of patient harm related to the potential cybersecurity risks.

Read More